Mary-Brenda Akoda, winner of NPSI, during her public presentation in Abuja, Monday
Developed by Mary-Brenda Akoda, GenScan AI uses artificial intelligence to shorten MRI scan times while maintaining or improving image quality.
Nigeria LNG Limited (NLNG) Monday presented GenScan AI, the winning work of The Nigeria Prize for Science and Innovation (NPSI) 2026 to stakeholders in Abuja highlighting its potential to accelerate magnetic resonance imaging (MRI) and improve access to diagnostic services.
Developed by Mary-Brenda Akoda, GenScan AI uses artificial intelligence to shorten MRI scan times while maintaining or improving image quality. The presentation brought together stakeholders to explore its potential application in Nigeria’s health sector and the steps required to translate the research into clinical use.
According to the Advisory Board of NPSI, who declared the prize winner, “its C-MORE algorithm uses a one-step framework to reconstruct MRI images, with the potential to reduce scan acquisition times by up to 90 per cent without requiring new MRI hardware”.
By shortening scan times, the technology could enable healthcare providers to attend to more patients, reduce waiting times and make better use of existing MRI equipment. These potential benefits informed the recognition of its relevance to healthcare delivery.
In her welcome remarks, Sophia Horsfall, NLNG’s General Manager, External Relations and Sustainable Development, emphasised the importance of accurate diagnosis to effective treatment. She noted that diagnostic imaging provides evidence that helps medical teams identify conditions and make informed decisions about patient care.
“Our interest goes beyond recognising an outstanding idea. We want to see scientific research make a practical difference in people’s lives. GenScan AI offers the prospect of faster medical imaging and better use of existing equipment. This presentation creates an opportunity to discuss what is needed to move that promise towards practical application.”
Speaking on the winning entry, Professor Barth Nnaji, the Prize’s Advisory Board, said the winning work stood out for the strength of its science and its potential to address a practical healthcare need.
He identified engagement with clinicians and other stakeholders as the next step in assessing how the technology could be used safely and effectively. The presentation, he added, offered an opportunity to examine its potential and the requirements for further development and application.
Akoda emerged as the 2026 winner from a record 237 entries submitted under the theme, “Innovations in Artificial Intelligence, ICT and Digital Technologies for Development”. Her selection followed an independent evaluation by the Panel of Judges, chaired by Dr Omobola Johnson, and endorsement by the Advisory Board.
She is the first woman and the first millennial to win the Prize as an individual recipient and is scheduled to receive the US$100,000 award at the Grand Award Night on 9 October 2026.
Sponsored by NLNG, The Nigeria Prize for Science and Innovation recognises excellence in scientific research and promotes innovations that address practical challenges. The public presentation advances this objective by connecting winning research with institutions and professionals who can help translate its potential into tangible benefits for society.
